![Joan Fusco](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joan Fusco
Operationeel Directeur bij Public Health Vaccines LLC
Profiel
Joan Fusco is the Chief Operating Officer at Public Health Vaccines LLC.
Previously, she was the Vice President-Technical Affairs at Baxter Healthcare Corp.
from 2000 to 2004, and the Senior Vice President-Operations at Acambis Plc from 2004 to 2008.
She also held the position of Senior Vice President-Operations at PharmAthene, Inc. Dr. Fusco received her undergraduate and doctorate degrees from the University of Pittsburgh.
Actieve functies van Joan Fusco
Bedrijven | Functie | Begin |
---|---|---|
Public Health Vaccines LLC
![]() Public Health Vaccines LLC BiotechnologyHealth Technology Public Health Vaccines LLC is a privately-held biotechnology company that develops vaccines for the prevention and control of emerging infectious diseases. The company is based in Cambridge, MA. The company's initial focus was to develop vaccines against Marburg virus and Sudan ebolavirus utilizing the RVSV platform in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). | Operationeel Directeur | 01-01-2018 |
Eerdere bekende functies van Joan Fusco
Bedrijven | Functie | Einde |
---|---|---|
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Operationeel Directeur | 01-01-2008 |
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01-10-2004 |
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Operationeel Directeur | - |
Opleiding van Joan Fusco
University of Pittsburgh | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Public Health Vaccines LLC
![]() Public Health Vaccines LLC BiotechnologyHealth Technology Public Health Vaccines LLC is a privately-held biotechnology company that develops vaccines for the prevention and control of emerging infectious diseases. The company is based in Cambridge, MA. The company's initial focus was to develop vaccines against Marburg virus and Sudan ebolavirus utilizing the RVSV platform in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). | Health Technology |